Imaging bacteria with radiolabelled quinolones, cephalosporins and siderophores for imaging infection: a systematic review

Clinical and Translational Imaging

Volumn 4, Issue 4, 2016, Pages 229-252

  Auletta, S ^a   Galli, F ^a   Lauri, C ^a   Martinelli, D ^b   Santino, I ^b   Signore, Alberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antibiotics; Bacteria; Infection; Molecular imaging; Radiolabelled antibiotic

Indexed keywords

CEFOPERAZONE; CEPHALOSPORIN; CIPROFLOXACIN; ERYTHROMYCIN; MEBENDAZOLE; QUINOLONE; SIDEROPHORE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; COMPUTER ASSISTED RADIOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RNA INTERFERENCE; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 85006201154     PISSN: 22815872     EISSN: 22817565     Source Type: Journal    
DOI: 10.1007/s40336-016-0185-8     Document Type: Review

References (125)

1. Signore A (2014) The need of shared diagnostic protocols. Q J Nucl Med Mol Imaging 58:1
2. 99mTc-labeled antibiotics for infection detection. Ann Nucl Med 25:1–6. doi:10.1007/s12149-010-0417-3
3. Oyen WJG, Corstens FHM, Boerman OC (2005) Discriminating infection from sterile inflammation: can radiolabelled antibiotics solve the problem? Eur J Nucl Med Mol Imaging 32:151–152. doi:10.1007/s00259-004-1722-7
4. Palestro CJ, Glaudemans AWJM, Dierckx RAJO (2013) Multiagent imaging of inflammation and infection with radionuclides. Clin Transl Imaging 1:385–396. doi:10.1007/s40336-013-0041-z
5. Shah M, Garg G, Dadachova E (2015) Preclinical testing of radiopharmaceuticals for novel applications in HIV, bacterial and fungal infectious diseases. Q J Nucl Med Mol Imaging 59:317–326
6. Malviya G, Galli F, Sonni I, Signore A (2014) Imaging T-lymphocytes in inflammatory diseases: a nuclear medicine approach. Q J Nucl Med Mol Imaging 58:237–257
7. Signore A, D’Alessandria C, Lazzeri E, Dierckz R (2008) Can we produce an image of bacteria with radiopharmaceuticals? Eur J Nucl Med Mol Imaging 35:1051–1055. doi:10.1007/s00259-008-0762-9
8. 99mTc-1nfecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet 347:233–235
9. 99mTc-sparafloxacin complex, a novel agent for detecting sites of infection. J Label Compd Radiopharm 52:415–418
10. Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167–193
11. Jacoby GA (2005) Mechanisms of resistance to quinolones. Clin Infect Dis 15(41 Suppl 2):S120–S126
12. Hooper DC (2003) Mechanisms of quinolone resistance. In: Hooper DC, Rubinstein E (eds) Quinolone antimicrobial agents, 3rd edn. American Society for Microbiology, Washington, DC, pp 41–67
13. 18F]Ciprofloxacin, a new Positron Emission Tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans. Antimicrob Agents Chemother 48:3850–3857. doi:10.1128/AAC.48.10.3850-3857.2004
14. Bhardwaj N, Bhatnagar A, Singh AK (2005) Development and evaluation of a single vial cold kit for infection imaging: Tc-99m Ciprofloxacin. World J Nucl Med 4:244–251
15. Das SS, Britton KE, Solanki KK, Wareham DW (2000) Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 27:1865–1868. doi:10.1007/s002590000378
16. 99mTc-ciprofloxacin by different methods and its biodistribution. Appl Radiat Isot 57:193–200
17. 67Ga-Citrate scintigraphy to discriminate infection foci induced by Staphylococcus Aureus from sterile inflammation induced by Carrageenan in rat. Iran J Nucl Med 23:96–102
18. 68Ga-labeled ciprofloxacin conjugates as radiotracers for targeting bacterial infection. Chem Biol Drug Des. doi:10.1111/cbdd.12701
19. 99mTc-ciprofloxacin for diagnosis of bacterial infection. J Physics. doi:10.1088/1742-6596/611/1/012029
20. 99mTc-labeled ciprofloxacin in mice. Chin Med J 122:1907–1909
21. Dahiya S, Chuttani K, Khar RK, Saluja D, Mishra AK, Chopra M (2009) Synthesis and evaluation of ciprofloxacin derivatives as diagnostic tools for bacterial infection by Staphylococcus Aureus. Metallomics 1:409–417
22. 99mTc-ciprofloxacin as an infection imaging agent. Iran J Nucl Med 18:45–51
23. 99mTc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus Aureus prosthetic joint infection. J Nucl Med 43:239–245
24. 99mTc-ciprofloxacin scintigraphy and computed tomography. World J Gastroenterol 19:4897–4906
25. 99mTc-ciprofloxacin in imaging of clinical infections in camelids and a goat. Vet Radiol Ultrasound 46:340–347
26. 99mTc-ciprofloxacin (Infecton) scan. Vet Radiol Ultrasound 43:178–182
27. 18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging 32:143–150. doi:10.1007/s00259-004-1646-2
28. Britton KE, Vinjamuri S, Hall AV, Solanki K, Siraj QH, Bomanji J, Das S (1997) Clinical evaluation of technetium-99 m infecton for the localisation of bacterial infection. Eur J Nucl Med 24:553–556
29. Das SS, Britton KE (2003) Bacterial infection imaging. World J Nucl Med 2:173–179
30. 99mTc-ciprofloxacin, a promising agent for the diagnosis of bacterial infection. Eur J Nucl Med 28:570–574. doi:10.1007/s002590100488
31. 99mTechnetium-ciprofloxacin scintigraphy for the evaluation of spinal infections. Clin Orthop Rel Res 444:34–37
32. 99mTc-Infecton, a novel agent for detecting sites of infection. J Clin Pathol 51:215–219
33. 99mTc-ciprofloxacin (Infecton). J Clin Pathol 55:817–823
34. 99mTc white blood cell and three-phase bone imaging in the diagnosis of hip prosthesis infections: improved diagnostic accuracy with extended imaging time. Nucl Med Comm 23:655–661
35. Lee M, Yoon M, Hwang KH, Choe W (2010) Tc-99m ciprofloxacin SPECT of pulmonary tuberculosis. Nucl Med Mol Imaging 44:116–122. doi:10.1007/s13139-010-0021-4
36. 99mTc-ciprofloxacin. Hepato-gastroenterol 52:491–495
37. Obradović V, Artiko V, Petrović N, Davidović B, Nikolić N, Vucetic C, Sobic-Saranovic D, Todorovic-Tirnanic M, Vlajković M (2003) Preliminary results of imaging orthopaedic infection with Tc-99m ciprofloxacin using a newly developed simple labelling kit. World J Nucl Med 2:269–274
38. Amaral H, Morales B, Pruzzo R, Britton K (1999) Cold-hot mismatch between Tc-99m HMPAO–labeled leukocytes and Tc-99m ciprofloxacin in axial skeleton infections: a report of three cases. Clin Nucl Med 24:855–858
39. Malamitsi J, Papadopoulos A, Vezyrgianni A, Dalianis K, Boutsikou M, Giamarellou H (2011) The value of successive Infecton scans in assessing the presence of chronic bone and joint infection and in predicting its evolution after treatment and after a prolonged follow-up. Nucl Med Commun 32:1060–1069
40. Choe Y, Choe W, Lee K, Ahn S, Kim K, Cho YU, Choi SK, Hur Y, Kim S, Hong K, Shin S, Kim K, Woo Z (2007) Tc-99m ciprofloxacin imaging in acute cholecystitis. World J Gastroenterol 13:3249–3252
41. 99mTc-ciprofloxacin scintigraphy in the diagnosis of prosthetic joint infections. Nucl Med Commun 32:44–51
42. 99mTc-ciprofloxacin (Infecton) imaging in the diagnosis of knee prosthesis infections. Nucl Med Commun 23:167–170
43. Sharma R, Mondal A, Sharma M, Popli M, Chopra MK, Sawroop K, Kashyap R (2001) Tc-99m infecton scan in possible pelvic inflammatory disease. Clin Nucl Med 26:208–211
44. Sharma R, Tewari KN, Bhatnagar A, Mondal A, Mishra AK, Singh AK, Chopra MK, Rawat H, Kashyap R, Tripathi RP (2007) Tc-99m ciprofloxacin scans for detection of tubercular bone infection. Clin Nucl Med 32:367–370
45. 99mTc-ciprofloxacin in the detection of bacterial infection: an Indian experience. Nucl Med Comm 29:1123–1129
46. 99mTc-HMPAO leukocyte scintigraphy. J Nucl Med 42:567–574
47. 99mTc–ciprofloxacin radiopharmaceutical for the detection of bone infection. Clin Microbiol Infect 9:101–109
48. 99mTc-ciprofloxacin scintigraphy for the diagnosis of osteomyelitis in the diabetic foot. Foot Ankle Int 27:716–722
49. Gallowitsch HJ, Heinisch M, Mikosch P, Kresnik E, Kumnig G, Gomez I, Lind P (2002) Tc-99m ciprofloxacin in clinically selected patients for peripheral osteomyelitis, spondylodiscitis and fever of unknown origin–preliminary results. Nuklearmedizin 41:30–36
50. 99mTc ciprofloxacin scan. Int Orthop 35:1869–1874
51. Dumarey N, Blocklet D, Appelboom T, Tant L, Schoutens A (2002) Infecton is not specific for bacterial osteo-articular infective pathology. Eur J Nucl Med 29:530–535. doi:10.1007/s00259-001-0749-2
52. 99mTc-Ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine: experience in 48 patients. Eur J Nucl Med Mol Imaging 31:233–239. doi:10.1007/s00259-003-1349-0
53. 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med 44:920–926
54. 99mTc-ciprofloxacin accumulation indexes in bone and joint bacterial infections. Vojnosanit Pregl 66:395–398
55. 99mTc ciprofloxacin imaging for the diagnosis of infection in the postoperative spine. Nucl Med Comm 25:277–283
56. Appelboom T, Emery P, Tant L, Dumarey N, Schoutens A (2003) Evaluation of technetium-99m-ciprofloxacin (Infecton) for detecting sites of inflammation in arthritis. Rheumatol 42:1179–1182
57. 99mTcN complex of ciprofloxacin dithiocarbamate as a potential agent for infection imaging. Bioorg Med Chem Lett 18:5168–5170
58. 3 complex of ciprofloxacin dithiocarbamate as a potential agent to target infection. Bioorg Med Chem Lett 20:3781–3784
59. Ball P, Tillotson G (1995) Tolerability of fluoroquinolone antibiotics. Past, present and future. Drug Saf 13:343–358
60. King DE, Malone R, Lilley SH (2000) New classification and update on the quinolone antibiotics. Am Fam Physician 61:2741–2748
61. 99mTc-pefloxacin: a new targeting agent for infectious foci. J Radioanal Nucl Chem 266:131–139
62. 99mTc-ofloxacin complexes. J Radioanal Nucl Chem 272:95–99. doi:10.1007/s10967-006-6786-3
63. 99mTc-tricabonyl labeling of ofloxacin and its biological evaluation in Staphylococcus aureus as an infection imaging agent. J Label Compd Radiopharm 56:627–631. doi:10.1002/jlcr.3093
64. 99mTc-ciprofloxacin. J Nucl Med 45:2088–2094
65. 99mTc-enorfloxacin: an infection imaging agent. Lat Am J Pharm 35:259–264
66. 99mTc–norfloxacin complex, a novel agent for detecting sites of infection. J Radioanal Nucl Chem 285:431–436. doi:10.1007/s10967-010-0607-4
67. Sazonova SI, Lishmanov YB, Varlamova NV, Skuridin VS, Ilushenkova YN, Karpova MR, Nesterov YA (2015) Synthesis and experimental study of norfloxacin labeled with technecium-99m as a potential agent for infection imaging. Iran J Nucl Med 23:73–81
68. 99mTcN complex of norfloxacin dithiocarbamate as a potential agent for bacterial infection imaging. Bioconjugate Chem 22:369–375
69. Andriole VT (2005) The quinolones: past, present and future. Clin Infect Dis 41:113–119. doi:10.1086/428051
70. 99mTc-levofloxacin freeze dried kits in Salmonella typhi, Pseudoman aeruginosa, and Escherichia coli. Lat Am J Pharm 34:760–765
71. 99mTc-rufloxacin complex as a model for detecting sites of infection. Radiochem 55:610–614. doi:10.1134/S1066362213060088
72. 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography. Antimicrob Agents Chem 36:2286–2292
73. Mather R, Karenchak LM, Romanowski EG, Kowalski RP (2002) Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Oph 133:463–466
74. 99mTc-sitafloxacin kit: a novel infection imaging agent. J Radioanal Nucl Chem 284:189–193. doi:10.1007/s10967-010-0470-3
75. 99mTcN-sitafloxacin dithiocarbamate as a potential radiotracer for Staphylococcus aureus infection. J Radioanal Nucl Chem 287:827–832. doi:10.1007/s10967-010-0833-9
76. 99mTc-moxifloxacin, a potential infection specific imaging agent. Appl Radia Isot 68:314–316. doi:10.1016/j.apradiso.2009.10.030
77. Qaiser SS, Khan MR (2011) Radiolabeling of gemifloxacin with technetium-99m and biological evaluation in artificially Streptococcus pneumoniae infected rats. J Radioanal Nucl Chem 288:307–312. doi:10.1007/s10967-010-0916-7
78. 99mTc-gemifloxacin freeze dried kits and their biodistribution in Salmonella typhi, Pseudomonas aeruginosa and Klebsiella pneumonia. Arab J Chem. doi:10.1016/j.arabjc.2015.10.002
79. Moustapha ME, Motaleb MA, Shweeta H, Farouk M (2016) Synthesis and biological evaluation of technetium-sarafloxacin complex for infection imaging. J Radioanal Nucl Chem 307:699–705. doi:10.1007/s10967-015-4188-0
80. 99mTc-cefazolin complex, a novel agent for detecting sites of infection. J Radioanal Nucl Chem 298:1215–1220
81. 99mTc cefuroxime axetil for imaging of inflammation. J Radioanal Nucl Chem 277:491–494. doi:10.1007/s10967-007-7111-5
82. Chattopadhyay S, Ghosh M, Sett S, Das MK, Chandra S, De K, Mishra M, Sinha S, Sarkar BR, Ganguly S (2012) Preparation and evaluation of 99mTc-cefuroxime, a potential infection specific imaging agent: a reliable thin layer chromatographic system to delineate impurities from the 99mTc-antibiotic. Appl Radia Isot 70:2384–2387
83. Klein NC, Cunha BA (1995) Third-generation cephalosporins. Med Clin North Am 79:705–719
84. 99mTc-ceftizoxima en ratas normales y en ratas con absceso inducido. Rev Esp Med Nucl 24:312–318
85. Costa PHN, Diniz SOF, Cardoso VN, Tarabal B, Takenaka I, Braga O, Vidigal PVT, Gelape CL, Araujo ID (2015) Scintigraphic imaging with technetium-99 M-labelled ceftizoxime is a reliable technique for the diagnosis of deep sternal wound infection in rats. Acta Cirurgica Brasileira 30:632–638
86. 99mTc-labeled ceftizoxime in the diagnosis of subclinical infections associated with titanium implants in rats. Surg Inf 16:352–357
87. 99mTc-cefotaxime as an infection imaging agent. J Radioanal Nucl Chem 287:21–25. doi:10.1007/s10967-010-0826-8
88. 99mTc-cefotaxime sodium in preclinical models of bacterial infection and sterile inflammation. J Label Compd Radiopharm 59:109–116
89. 99mTc generator based on zirconium molybdate. Appl Radiat Isot 68:1959–1963. doi:10.1016/j.apradiso.2010.04.031
90. Kaul A, Hazari PP, Rawat H, Singh B, Kalawat TC, Sharma S, Babbar AK, Mishra AK (2012) Preliminary evaluation of technetium-99m-labeled ceftriaxone: infection imaging agent for the clinical diagnosis of orthopedic infection. Int J Infect Dis 17(4):e263–e270. doi:10.1016/j.ijid.2012.10.011
91. 99mTc-ceftriaxone, as a targeting radiopharmaceutical for scintigraphic imaging of infectious foci due to Staphylococcus aureus in mouse model. J Radioanal Nucl Chem 298:1227–1233. doi:10.1007/s10967-013-2523-x
92. 99mTc and its bio-evaluation as an infection imaging agent. J Label Compd Radiopharm 57:652–657
93. 99mTc-ceftazidime as bacterial infection imaging agent. J Radioanal Nucl Chem 298:19–24. doi:10.1007/s10967-013-2418-x
94. 99mTc-cefoperazone complex, a novel agent for detecting sites of infection. J Radioanal Nucl Chem 272:167–171. doi:10.1007/s10967-006-6754-y
95. 99mTc–cefepime complexes. J Radioanal Nucl Chem 289:57–65. doi:10.1007/s10967-011-1058-2
96. Hunt R, Microbiology and immunology online, University of South Carolina School of Medicine
97. Ankrah AO, van der Werf TS, de Vries EFJ, Dierckx RAJO, Sathegke MM, Glaudemans AWJM (2016) PET/CT imaging of mycobacterium tuberculosis infection. Clin Transl Imaging. 4:131–144. doi:10.1007/s40336-016-0164-0
98. 99mTc-rifampicin: a novel radiotracer for in vivo infection imaging. Appl Radiat Isot 68:2255–2260. doi:10.1016/j.apradiso.2010.05.014
99. Komp Lindgren P, Klockars O, Malmberg C, Cars O (2015) Pharmacodynamic studies of nitrofurantoin against common uropathogens. J Antimicrob Chemother 70:1076–1082. doi:10.1093/jac/dku494
100. 99mTc-nitrofurantoin a novel radiotracer for in vivo imaging of Escherichia Coli infection. J Radioanal Nucl Chem 287:417–422. doi:10.1007/s10967-010-0697-z
101. Silver LL (2003) Novel inhibitors of bacterial cell wall synthesis. Curr Opin Microbiol 6:431–438. doi:10.1016/j.mib.2003.08.004
102. Andes D, Craig WA (1998) In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus Pneumoniae: application to breakpoint determinations. Antimicrob Agents Chemother 42:2375–2379
103. 99mTc-amoxicillin: a novel radiopharmaceutical for infection imaging. Arabian J Chem. doi:10.1016/j.arabjc.2015.04.003
104. Atherton FR, Hall MJ, Hassal CH, Lambert RW, Lloyd WJ, Ringrose PS (1979) Phosphonopeptides as antibacterial agents: mechanism of action of alaphosphin. Antimicrob Agents Chemother 15:696–705
105. 99mTc-alafosfalin: an antibiotic peptide infection imaging agent. Nucl Med Biol 30:169–175
106. 18F]fluoroacetamido-D-glucopyranose and its evaluation as a bacterial infections imaging agent. Nucl Med Biol 38:807–817. doi:10.1016/j.nucmedbio.2011.02.006
107. Neu HC, Gootz TD (1996) Antimicrobial chemotherapy. In: Baron S (ed) Medical microbiology, 4th edn, chapter 11, Galveston (TX): University of Texas Medical Branch at Galveston
108. 99mTc-vancomycin in a model of bacterial infection. Radiochim Acta 93:415–418
109. Lowy F (2009) Protein synthesis inhibitors. Division of Infectious Diseases, University of Columbia
110. 99mTc-kanamycin. J Radioanal Nucl Chem 262:561–566
111. İlem-Özdemir D, Asikoglu M, Ozkilic H et al (2014) 99mTc-doxycycline hyclate: a new radiolabeled antibiotic for bacterial infection imaging. J Label Compd Radiopharm 57:36–41. doi:10.1002/jlcr.3135
112. 99mTc- erythromycin complex as a model for infection sites imaging. Radiochem 55:418–422. doi:10.1134/S1066362213040139
113. 99mTc-vibramycin for infection sites imaging. Bulg Chem Comm 47:747–754
114. Yang ZY, Wang L, Tang X (2009) Determination of azithromycin by ion-pair HPLC with UV detection. J Pharm Biomed Anal 49:811–815. doi:10.1016/j.jpba.2008.12.018
115. 99mTc-azithromycin for infective inflammation diagnosis. Radiochem 55:539–544. doi:10.1134/S1066362213050159
116. 99mTc-Clarithromycin for Infective Inflammation Diagnosis. Radiochem 58:84–91
117. Morar M, Bhullar K, Hughes DW, Junop M, Wright GD (2009) Structure and mechanism of the lincosamide antibiotic adenylyltransferase linB. Structure 17:1649–1659. doi:10.1016/j.str.2009.10.013
118. 99mTc-clindamycin: an infection imaging agent. Appl Biochem Biotechnol 174:1420–1433. doi:10.1007/s12010-014-1075-z
119. de la Torre-Iglesias PM, Garcìa-Rodriguez JJ, Torrado G, Torrado S, Torrado-Santiago S, Bolàs-Fernàndez S (2014) Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose. Drug Des Devel Ther 18:1467–1479. doi:10.2147/DDDT.S65561
120. Inceboz T, Yurt Lambrecht F, Yilmaz O et al (2012) Technetium-99m labeled mebendazole and biodistribution in experimentally Trichinella spiralis-infected rats. Med Chem Res 21:804–809. doi:10.1007/s00044-011-9590-8
121. Ning X, Lee S, Wang Z, Kim D, Stubblefield B, Gilbert E, Murthy N (2011) Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. Nat Mat 10:602–607. doi:10.1038/NMAT3074
122. 18F]-fluoromaltose as a novel PET tracer for imaging bacterial infection. PLoS ONE 9(9):e107951
123. 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus Fumigatus infection imaging. Eur J Nucl Med Mol Imaging 39:1175–1183. doi:10.1007/s00259-012-2110-3
124. 68Ga-ferrioxamine E for Aspergillus infection imaging: uptake specificity in various microorganisms. Mol Imaging Biol 16:102–108. doi:10.1007/s11307-013-0654-7
125. 99mTc-8-hydroxy-7-substituted quinoline complex: a novel agent for infection imaging. J Radioanal Nucl Chem 287:61–67. doi:10.1007/s10967-010-0818-8